Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 8346301, 6 pages
http://dx.doi.org/10.1155/2016/8346301
Research Article

Metabolic Syndrome Augments the Risk of Early Neurological Deterioration in Acute Ischemic Stroke Patients Independent of Inflammatory Mediators: A Hospital-Based Prospective Study

1Department of Neurology, Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210002, China
2Department of Gastroenterology, Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210002, China
3Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, China

Received 5 December 2015; Accepted 17 March 2016

Academic Editor: Vladimir Jakovljevic

Copyright © 2016 Xiaohao Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Liu, B. Wu, W.-Z. Wang, L.-M. Lee, S.-H. Zhang, and L.-Z. Kong, “Stroke in China: epidemiology, prevention, and management strategies,” The Lancet Neurology, vol. 6, no. 5, pp. 456–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Seners, G. Turc, C. Oppenheim, and J.-C. Baron, “Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 86, no. 1, pp. 87–94, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Thanvi, S. Treadwell, and T. Robinson, “Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management,” Postgraduate Medical Journal, vol. 84, no. 994, pp. 412–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Rajajee, C. Kidwell, S. Starkman et al., “Early MRI and outcomes of untreated patients with mild or improving ischemic stroke,” Neurology, vol. 67, no. 6, pp. 980–984, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. F. Arenillas, Á. Rovira, C. A. Molina, E. Grivé, J. Montaner, and J. Álvarez-Sabín, “Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke,” Stroke, vol. 33, no. 9, pp. 2197–2203, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Sun, W. Liu, Z. Zhang et al., “Asymmetrical cortical vessel sign on susceptibility-weighted imaging: a novel imaging marker for early neurological deterioration and unfavorable prognosis,” European Journal of Neurology, vol. 21, no. 11, pp. 1411–1418, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Duan, C. Fu, B. Chen et al., “Lesion patterns of single small subcortical infarct and its association with early neurological deterioration,” Neurological Sciences, vol. 36, no. 10, pp. 1851–1857, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Santaniemi, O. Ukkola, E. Malo, R. Bloigu, and Y. A. Kesäniemi, “Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin,” European Journal of Preventive Cardiology, vol. 21, no. 10, pp. 1242–1248, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. J. B. Li, X. Wang, J.-X. Zhang et al., “Metabolic syndrome: prevalence and risk factors in Southern China,” Journal of International Medical Research, vol. 38, no. 3, pp. 1142–1148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. E. V. Balti, A. P. Kengne, J. V. F. Fokouo, B. E. Nouthé, and E. Sobngwi, “Metabolic syndrome and fatal outcomes in the post-stroke event: a 5-year cohort study in Cameroon,” PLoS ONE, vol. 8, no. 4, Article ID e60117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Y. Oh, S. B. Ko, S. H. Lee et al., “Association between metabolic syndrome and functional outcome in patients with acute ischaemic stroke,” European Journal of Neurology, vol. 21, no. 1, pp. 177–179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Ding, S. Li, R.-L. Ma et al., “Association of homeostasis model assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome,” Clinical Biochemistry, vol. 48, no. 7-8, pp. 503–507, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Jin, L. Liu, S. Zhang, A. Nanda, and G. Li, “Role of inflammation and its mediators in acute ischemic stroke,” Journal of Cardiovascular Translational Research, vol. 6, no. 5, pp. 834–851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. J. Adams, B. Bendixen, L. Kappelle et al., “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Google Scholar
  15. H. J. Adams, Z. G. del, M. Alberts et al., “Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists,” Criculation, vol. 115, no. 20, pp. e478–e534, 2007. View at Google Scholar
  16. H.-M. Kwon, Y.-S. Lee, H.-J. Bae, and D.-W. Kang, “Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke,” Stroke, vol. 45, no. 3, pp. 871–873, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-M. Kwon, J.-S. Lim, H.-K. Park, and Y.-S. Lee, “Hypertriglyceridemia as a possible predictor of early neurological deterioration in acute lacunar stroke,” Journal of the Neurological Sciences, vol. 309, no. 1-2, pp. 128–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Alawneh, R. R. Moustafa, and J.-C. Baron, “Hemodynamic factors and perfusion abnormalities in early neurological deterioration,” Stroke, vol. 40, no. 6, pp. e443–e450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Y. Poppe, S. R. Majumdar, T. Jeerakathil, W. Ghali, A. M. Buchan, and M. D. Hill, “Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis,” Diabetes Care, vol. 32, no. 4, pp. 617–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Leigh, O. O. Zaidat, M. F. Suri et al., “Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy,” Stroke, vol. 35, no. 8, pp. 1903–1907, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Ennis and R. F. Keep, “Effect of sustained-mild and transient-severe hyperglycemia on ischemia-induced blood-brain barrier opening,” Journal of Cerebral Blood Flow α Metabolism, vol. 27, no. 9, pp. 1573–1582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Vila, J. Castillo, A. Dávalos, and Á. Chamorro, “Proinflammatory cytokines and early neurological worsening in ischemic stroke,” Stroke, vol. 31, no. 10, pp. 2325–2329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Castellanos, J. Castillo, M. M. García et al., “Inflammation-mediated damage in progressing lacunar infarctions a potential therapeutic target,” Stroke, vol. 33, no. 4, pp. 982–987, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Vila, J. Castillo, A. Dávalos, A. Esteve, A. M. Planas, and Á. Chamorro, “Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke,” Stroke, vol. 34, no. 3, pp. 671–675, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. H. K. Eltzschig and P. Carmeliet, “Hypoxia and inflammation,” The New England Journal of Medicine, vol. 364, no. 7, pp. 656–665, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Liu, J. Wang, B. Jiang et al., “Increasing prevalence of metabolic syndrome in a Chinese elderly population: 2001–2010,” PLoS ONE, vol. 8, no. 6, Article ID e66233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Mottillo, K. B. Filion, J. Genest et al., “The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis,” Journal of the American College of Cardiology, vol. 56, no. 14, pp. 1113–1132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-H. Choi, M.-S. Park, J.-T. Kim et al., “Serum triglyceride level is an important predictor of early prognosis in patients with acute ischemic stroke,” Journal of the Neurological Sciences, vol. 319, no. 1-2, pp. 111–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. J. F. Arenillas, M. A. Moro, and A. Dávalos, “The metabolic syndrome and stroke: potential treatment approaches,” Stroke, vol. 38, no. 7, pp. 2196–2203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Vidula, K. Liu, M. H. Criqui et al., “Metabolic syndrome and incident peripheral artery disease—the Multi-Ethnic Study of Atherosclerosis,” Atherosclerosis, vol. 243, no. 1, pp. 198–203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Conen, K. M. Rexrode, M. A. Creager, P. M. Ridker, and A. D. Pradhan, “Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women. A prospective study,” Circulation, vol. 120, no. 12, pp. 1041–1047, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Abu-Farha, K. Behbehani, and N. Elkum, “Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs,” Cardiovascular Diabetology, vol. 13, no. 1, article 76, pp. 1–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. W.-K. Seo, H.-Y. Seok, J. H. Kim et al., “C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 21, no. 3, pp. 181–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Nardi, P. Milia, P. Eusebi, M. Paciaroni, V. Caso, and G. Agnelli, “Admission leukocytosis in acute cerebral ischemia: influence on early outcome,” Journal of Stroke and Cerebrovascular Diseases, vol. 21, no. 8, pp. 819–824, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. K. J. Tracey, “The inflammatory reflex,” Nature, vol. 420, no. 6917, pp. 853–859, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Spranger, A. Kroke, M. Möhlig et al., “Adiponectin and protection against type 2 diabetes mellitus,” The Lancet, vol. 361, no. 9353, pp. 226–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. K. S. De Bona, G. Bonfanti, P. E. R. Bitencourt et al., “Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index,” Inflammation, vol. 36, no. 6, pp. 1539–1547, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Z. Banderas, J. Escobedo, E. Gonzalez, M. G. Liceaga, J. C. Ramírez, and M. G. Castro, “γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome,” European Journal of Gastroenterology and Hepatology, vol. 24, no. 7, pp. 805–810, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. E. Siegler and S. S. Martin, “Early Neurological Deterioration (END) after stroke: the END depends on the definition,” International Journal of Stroke, vol. 6, no. 3, pp. 211–212, 2011. View at Publisher · View at Google Scholar · View at Scopus